<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rudilosso S</submitter><funding>Fondo de Investigacions Sanitarias of the Institut de Salud Carlos III to Ángel Chamorro and Xabier Urra</funding><funding>Fondo Europeo de Desarrollo Regional</funding><funding>Institute of Health Carlos III</funding><funding>European Social Fund</funding><funding>Instituto de Salud Carlos III</funding><pagination>401-410</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8521260</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(3)</volume><pubmed_abstract>&lt;h4>Background and purpose&lt;/h4> In real-world practice, the benefit of mechanical thrombectomy (MT) is uncertain in stroke patients with very favorable or poor prognostic profiles at baseline. We studied the effectiveness of MT versus medical treatment stratifying by different baseline prognostic factors.&lt;h4>Methods&lt;/h4> Retrospective analysis of 2,588 patients with an ischemic stroke due to large vessel occlusion nested in the population-based registry of stroke code activations in Catalonia from January 2017 to June 2019. The effect of MT on good functional outcome (modified Rankin Score ≤2) and survival at 3 months was studied using inverse probability of treatment weighting (IPTW) analysis in three pre-defined baseline prognostic groups: poor (if pre-stroke disability, age >85 years, N</pubmed_abstract><journal>Journal of stroke</journal><pubmed_title>Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population-Based Registry.</pubmed_title><pmcid>PMC8521260</pmcid><funding_grant_id>FIS-ISCIII PI18/00444</funding_grant_id><funding_grant_id>INT19/00020</funding_grant_id><funding_grant_id>CM18/00116</funding_grant_id><pubmed_authors>Molina C</pubmed_authors><pubmed_authors>Sanjurjo E</pubmed_authors><pubmed_authors>Amaro S</pubmed_authors><pubmed_authors>Baiges J</pubmed_authors><pubmed_authors>Aragones JM</pubmed_authors><pubmed_authors>Rudilosso S</pubmed_authors><pubmed_authors>Gomis M</pubmed_authors><pubmed_authors>Llull L</pubmed_authors><pubmed_authors>Renu A</pubmed_authors><pubmed_authors>Rios J</pubmed_authors><pubmed_authors>Lopez MN</pubmed_authors><pubmed_authors>Cocho D</pubmed_authors><pubmed_authors>Rodriguez A</pubmed_authors><pubmed_authors>Matos N</pubmed_authors><pubmed_authors>de la Ossa NP</pubmed_authors><pubmed_authors>Canovas D</pubmed_authors><pubmed_authors>Jimenez-Fabrega FX</pubmed_authors><pubmed_authors>Terceno M</pubmed_authors><pubmed_authors>Cardona P</pubmed_authors><pubmed_authors>Roman LS</pubmed_authors><pubmed_authors>Torres F</pubmed_authors><pubmed_authors>Ustrell X</pubmed_authors><pubmed_authors>Almendros MC</pubmed_authors><pubmed_authors>Gomez-Choco M</pubmed_authors><pubmed_authors>Salvat-Plana M</pubmed_authors><pubmed_authors>Serena J</pubmed_authors><pubmed_authors>Urra X</pubmed_authors><pubmed_authors>Obach V</pubmed_authors><pubmed_authors>Rodriguez-Campello A</pubmed_authors><pubmed_authors>Marti-Fabregas J</pubmed_authors><pubmed_authors>Catena E</pubmed_authors><pubmed_authors>Rybyeba M</pubmed_authors><pubmed_authors>Barcelo M</pubmed_authors><pubmed_authors>Carrion D</pubmed_authors><pubmed_authors>Purroy F</pubmed_authors><pubmed_authors>Colom C</pubmed_authors><pubmed_authors>Vera V</pubmed_authors><pubmed_authors>Chamorro A</pubmed_authors><pubmed_authors>Diaz G</pubmed_authors><pubmed_authors>Costa X</pubmed_authors><pubmed_authors>Palomeras E</pubmed_authors><pubmed_authors>Catalan Stroke Code and Reperfusion (Cat-SCR) Consortium</pubmed_authors><pubmed_authors>Krupinski J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population-Based Registry.</name><description>&lt;h4>Background and purpose&lt;/h4> In real-world practice, the benefit of mechanical thrombectomy (MT) is uncertain in stroke patients with very favorable or poor prognostic profiles at baseline. We studied the effectiveness of MT versus medical treatment stratifying by different baseline prognostic factors.&lt;h4>Methods&lt;/h4> Retrospective analysis of 2,588 patients with an ischemic stroke due to large vessel occlusion nested in the population-based registry of stroke code activations in Catalonia from January 2017 to June 2019. The effect of MT on good functional outcome (modified Rankin Score ≤2) and survival at 3 months was studied using inverse probability of treatment weighting (IPTW) analysis in three pre-defined baseline prognostic groups: poor (if pre-stroke disability, age >85 years, N</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2026-05-08T16:08:26.236Z</modification><creation>2025-02-18T23:55:26.419Z</creation></dates><accession>S-EPMC8521260</accession><cross_references><pubmed>34649384</pubmed><doi>10.5853/jos.2021.00962</doi></cross_references></HashMap>